Utilising the power of cell-based medicines to deliver new therapies for the 21st Century
A new Cell and Gene Therapy Bioprocessing MBI¬Æ course will address the real-world challenges of translating discoveries to the clinic.
Cell and Gene Therapy is fast becoming an established field that aims to utilise the power of cell-based medicines to deliver new therapies for the 21st Century. However, translating the discovery science into manufacturable products has so far been challenging, and so multi-disciplinary engineers who possess unique skills are urgently needed to address the manufacture of these complex medicinal products.
The new Cell and Gene Therapy Bioprocessing MBI¬Æ course running at UCL from 9-11th July will address the real-world challenges of translating discoveries to the clinic in a way that is commercially viable. A series of lectures and interactive case studies will enable you to:
- Understand the distinctions of manufacturing cells compared with biologics
- Understand the challenges faced in advancing cell therapies to clinic and the lessons learned from established companies
- Understand the impact of design and engineering considerations on advanced therapy manufacture
- Identify and define critical process parameters for different advanced therapy applications
- Gain knowledge and application of analytical toolset for quality measurement
Photo galleries are not available for content from the previous KTN website: we apologise for this.
The course has an exciting line up of speakers including:
- Suzanne Farid, UCL
- Julian Hanak, NightStar Tx
- David Smith, Hitachi Chemical Advanced Therapeutics Solutions
- Damian Marshall, Cell and Gene Therapy Catapult
- Fernanda Masri, Sartorius
- Qasim Rafiq, UCL
- Kourosh Saeb-Parsy, Cambridge University Hospitals NHS Trust
- John Sinden, ReNeuron
- Glyn Stacey, formerly NIBSC
- Farlan Veraitch, UCL
For further information on the¬†Cell and Gene Therapy Bioprocessing MBI¬Æ course running at UCL from 9-11th July please click here.
About the MBI¬Æ programme
The award winning¬†MBI¬Æ programme is the largest international provider of innovative UCL-accredited short courses in bioprocessing, specifically created to support skills development of scientists and engineers working in the bioeng/bioprocess space or looking to move into these areas. All courses are designed and delivered in collaboration with 70 industrial experts to support continued professional and technical development. Courses are also integrated with departments‚Äô cutting edge transnational research to ensure information is current and forms a platform for knowledge transfer. MBI¬Æ is designed to be flexible with courses being taken stand-alone or combined for Certificate, Diploma or Masters qualifications. You can access a full list of courses here.